These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 29618675)

  • 1. Prevalence of Escherichia coli Resistant to Beta-Lactam Antibiotics among Patients with Chronic Obstructive Pulmonary Disease and Urinary Tract Infection.
    Nikolić E; Brandmajer T; Bokan V; Ulyashova M; Rubtsova M
    Tohoku J Exp Med; 2018 Apr; 244(4):271-277. PubMed ID: 29618675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors for community-onset urinary tract infections due to Escherichia coli harbouring extended-spectrum beta-lactamases.
    Calbo E; Romaní V; Xercavins M; Gómez L; Vidal CG; Quintana S; Vila J; Garau J
    J Antimicrob Chemother; 2006 Apr; 57(4):780-3. PubMed ID: 16492721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Analysis of antibiotic resistance and genotypes on extended spectrum β-lactamase and AmpC β-lactamase producing strains isolated from Uygur and Han newborns].
    Zhang WL; Liu J; Zhang J; Su GL
    Zhonghua Yu Fang Yi Xue Za Zhi; 2011 Mar; 45(3):217-24. PubMed ID: 21624232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CTX-M-producing Escherichia coli and Klebsiella pneumoniae isolated from community-acquired urinary tract infections in Valledupar, Colombia.
    Martinez P; Garzón D; Mattar S
    Braz J Infect Dis; 2012; 16(5):420-5. PubMed ID: 22964287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors for extended-spectrum beta-lactamase positivity in uropathogenic Escherichia coli isolated from community-acquired urinary tract infections.
    Azap OK; Arslan H; Serefhanoğlu K; Colakoğlu S; Erdoğan H; Timurkaynak F; Senger SS
    Clin Microbiol Infect; 2010 Feb; 16(2):147-51. PubMed ID: 19689464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasmid-mediated AmpC beta-lactamase-producing Escherichia coli causing urinary tract infection in the Auckland community likely to be resistant to commonly prescribed antimicrobials.
    Drinkovic D; Morris AJ; Dyet K; Bakker S; Heffernan H
    N Z Med J; 2015 Mar; 128(1410):50-9. PubMed ID: 25829039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of extended-spectrum beta-lactamases produced by Escherichia coli isolated from hospitalized and nonhospitalized patients: emergence of CTX-M-15-producing strains causing urinary tract infections.
    Smet A; Martel A; Persoons D; Dewulf J; Heyndrickx M; Claeys G; Lontie M; Van Meensel B; Herman L; Haesebrouck F; Butaye P
    Microb Drug Resist; 2010 Jun; 16(2):129-34. PubMed ID: 20370505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of the genes encoding extended-spectrum beta-lactamases, in Escherichia coli resistant to beta-lactam and non-beta-lactam antibiotics.
    Matar GM; Al Khodor S; El-Zaatari M; Uwaydah M
    Ann Trop Med Parasitol; 2005 Jun; 99(4):413-7. PubMed ID: 15949189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors for ciprofloxacin resistance among Escherichia coli strains isolated from community-acquired urinary tract infections in Turkey.
    Arslan H; Azap OK; Ergönül O; Timurkaynak F;
    J Antimicrob Chemother; 2005 Nov; 56(5):914-8. PubMed ID: 16174685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimicrobial susceptibility and mechanisms of fosfomycin resistance in extended-spectrum β-lactamase-producing Escherichia coli strains from urinary tract infections in Wenzhou, China.
    Bi W; Li B; Song J; Hong Y; Zhang X; Liu H; Lu H; Zhou T; Cao J
    Int J Antimicrob Agents; 2017 Jul; 50(1):29-34. PubMed ID: 28456703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spread of extended-spectrum beta-lactamase CTX-M-producing escherichia coli clinical isolates in community and nosocomial environments in Portugal.
    Mendonça N; Leitão J; Manageiro V; Ferreira E; Caniça M
    Antimicrob Agents Chemother; 2007 Jun; 51(6):1946-55. PubMed ID: 17371815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Investigation of ESBL types in community acquired urinary Escherichia coli isolates by isoelectric focusing and polymerase chain reaction].
    Dağlar D; Ongüt G; Oğünç D; Ozhak Baysan B; Demirbakan H; Sepin Özen N; Gültekin M
    Mikrobiyol Bul; 2010 Jul; 44(3):367-74. PubMed ID: 21063986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Predominant β-lactamase genotypes of Escherichia coli isolates and induction and inhibition mechanisms of β-lactamase gene expression].
    Tan P; Wang Z; Sun A; Yan J; Zhao J
    Zhonghua Liu Xing Bing Xue Za Zhi; 2015 May; 36(5):484-90. PubMed ID: 26080639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rise of community-onset urinary tract infection caused by extended-spectrum β-lactamase-producing Escherichia coli in children.
    Fan NC; Chen HH; Chen CL; Ou LS; Lin TY; Tsai MH; Chiu CH
    J Microbiol Immunol Infect; 2014 Oct; 47(5):399-405. PubMed ID: 23834784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distribution of ESBLs among Escherichia coli isolates from outpatients with recurrent UTIs and their antimicrobial resistance.
    Al-Mayahie S; Al Kuriashy JJ
    J Infect Dev Ctries; 2016 Jun; 10(6):575-83. PubMed ID: 27367005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mecillinam/clavulanate combination: a possible option for the treatment of community-acquired uncomplicated urinary tract infections caused by extended-spectrum β-lactamase-producing Escherichia coli.
    Lampri N; Galani I; Poulakou G; Katsarolis I; Petrikkos G; Giamarellou H; Souli M
    J Antimicrob Chemother; 2012 Oct; 67(10):2424-8. PubMed ID: 22665388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence and characterization of multidrug-resistant and extended-spectrum beta-lactamase-producing Escherichia coli from pediatric wards of a Malaysian hospital.
    Ho WS; Balan G; Puthucheary S; Kong BH; Lim KT; Tan LK; Koh XP; Yeo CC; Thong KL
    Microb Drug Resist; 2012 Aug; 18(4):408-16. PubMed ID: 22394084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and characterization of extended-spectrum beta-lactamase (ESBL)- and CMY-2-producing Escherichia coli isolates from healthy food-producing animals in Tunisia.
    Ben Sallem R; Ben Slama K; Sáenz Y; Rojo-Bezares B; Estepa V; Jouini A; Gharsa H; Klibi N; Boudabous A; Torres C
    Foodborne Pathog Dis; 2012 Dec; 9(12):1137-42. PubMed ID: 23194332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emergence of fosfomycin resistance among isolates of Escherichia coli harboring extended-spectrum and AmpC β-lactamases.
    Bahramian A; Eslami G; Hashemi A; Tabibi A; Heidary M
    Acta Microbiol Immunol Hung; 2018 Mar; 65(1):15-25. PubMed ID: 29137487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extended spectrum beta-lactamases in Escherichia coli & Klebsiella pneumoniae & associated risk factors.
    Goyal A; Prasad KN; Prasad A; Gupta S; Ghoshal U; Ayyagari A
    Indian J Med Res; 2009 Jun; 129(6):695-700. PubMed ID: 19692752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.